Search

In this study, 40 milk samples (10 raw cow milk, 10 camel milk, 10 pasteurised milk, and 10 ultra-high temperature milk) were randomly collected from Golestan Province (including two cities, Gorgan and Gonbad-e Kavus) from December 2021 to March 2022. Aflatoxin M1(AFM1) level was determined by the high-performance chromatography method. AFM1 was found in all samples. The mean concentration of AFM1 in raw cow milk, camel milk, pasteurised milk, and ultra-high temperature milk were 72.81 ± 2.18, 57.10 ± 1.86, 34.73 ± 1.34, and 49.36 ± 1.78 ng/kg, respectively. The highest level of AFM1 was found in raw cow milk (p < 0.05). According to the EU standard of AFM1 level, pasteurised milk is the safest type of milk in Golestan Province. [ABSTRACT FROM AUTHOR]

Aflatoxins are the most harmful mycotoxins that cause human and animal health concerns. Aflatoxin M1 (AFM1) is the primary hydroxylated metabolite of aflatoxin B1 and is linked to the development of hepatocellular carcinoma and immunotoxicity in humans and animals. Because of the important role of dairy products in human life, especially children, AFM1 is such a major concern to humans because of its frequent occurrence in dairy products at concentrations high enough to cause adverse effects to human and animal health. Reduced its bioavailability becomes a high priority in order to protect human and animal health. This study aimed to investigate, in vivo, the ability of lactic acid bacteria (lactobacillus rhamnosus GAF01, LR) and clay mineral (bentonite, BT) mixture to mitigate/reduce AFM1-induced immunotoxicity, hepatotoxicity, nephrotoxicity and oxidative stress in exposed Balb/c mice. The in vivo study was conducted using male Balb/c mice that treated, orally, by AFM1 alone or in combination with LR and/or BT, daily for 10 days as follows: group 1 control received 200 µl of PBS, group 2 treated with LR alone (2.108 CFU/mL), group 3 treated with BT alone (1 g/kg bw), group 4 treated with AFM1 alone (100 μg/kg), group 5 co-treated with LR + AFM1, group 6 co-treated with BT + AFM1, group 7 co-treated with BT + LR + AFM1. Forty-eight h after the end of the treatment, the mice were sacrificed and the blood, spleen, thymus, liver and kidney were collected. The blood was used for biochemical and immunological study. Spleen and thymus samples were used to thymocytes and splenocytes assessments. Liver and kidney samples were the target for evaluation of oxidative stress enzymes status and for histological assays. The results showed that AFM1 caused toxicities in male Blab/c mice at different levels. Treatment with AFM1 resulted in severe stress of liver and kidney organs indicated by a significant change in the biochemical and immunological parameters, histopathology as well as a disorder in the profile of oxidative stress enzymes levels. Also, it was demonstrated that AFM1 caused toxicities in thymus and spleen organs. The co-treatment with LR and/or BT significantly improved the hepatic and renal tissues, regulated antioxidant enzyme activities, spleen and thymus viability and biochemical and immunological parameters. LR and BT alone showed to be safe during the treatment. In summary, the LR and/or BT was able to reduce the biochemical, histopathological and immunological damages induced by AFM1 and indeed it could be exploited as one of the biological strategies for food and feedstuffs detoxification. [ABSTRACT FROM AUTHOR]

The study provides current information on the level of Aflatoxin M1 (AFM1) in three kinds of milk. This is the first report on AFM1 contamination in raw camel milk in the studied area. Seven raw camel milk, 21 raw cow milk, and 13 powdered milk samples were analysed with a highly sensitive competitive enzyme-linked immunosorbent assay (ELISA) kit. The results indicated that 14.63% (6/41) of all the analysed samples were positive, with an average concentration of 17.92ng/L, and a range of 5.5–42.5ng/L. It was found that only one sample (4.76%) of cow’s milk was positive, but all camels’ milk samples (100%) were free from Aflatoxin M1. The highest incidence and concentration (38.46%) was found in powdered milk with an average concentration of 20.34 ng/L. No analysed sample exceeded the limit set by European regulations (50 ng/L). This means that the milk analysed does not represent a consumer health hazard owing to the low concentration of Aflatoxin M1, but continuous monitoring is still needed to protect public health. [ABSTRACT FROM AUTHOR]

Aflatoxins are one of the highly toxic secondary metabolites with high decomposition temperatures, ranging from 237 °C to 306 °C. Therefore, non-thermal treatments are preferred to ensure safe food while preserving food quality. High voltage atmospheric cold plasma (HVACP) is a novel non-thermal technology with the potential to reduce contaminants (e.g. mycotoxins) owing to reactive species such as ozone. Therefore, the aim of this study was to investigate the efficacy of HVACP to degrade Aflatoxin M1 (AFM1) in pure water. A dielectric barrier discharge HVACP was performed at 90 kV using modified air (MA65: 65% O2, 30% CO2, 5% N2) fill gas for 1, 3, and 5 min in a direct and indirect mode with no post-treatment or 4.0 h post-storage at room temperature. The chemical properties of water were evaluated. Ozone concentration in both gas and liquid phases was also measured. A 77% reduction of AFM1 was observed after 1 min of direct treatment with no post-treatment storage. The nitrate and peroxide contents after 1 min of direct treatment were 4.50 ± 0.70 and 9.5 ± 0.70 mg/L, respectively. Longer treatment time and direct mode of exposure resulted in a higher ozone concentration in either the gas or liquid phase. These results demonstrate the potential of HVACP as a non-thermal treatment for reducing AFM1 concentration. HVACP was capable of significantly degrading AFM1 using a very short treatment time and 4.0-h post-treatment storage. [ABSTRACT FROM AUTHOR]

An efficient analytical method has been developed for the extraction and quantification of aflatoxin M1 in milk samples using a modified air-assisted liquid-liquid microextraction method combined with high-performance liquid chromatography-fluorescence detector. Firstly, defatted milk is transferred into a glass test tube and its proteins are participated with zinc acetate solution. After vortexing and centrifugation of the mixture, the obtained supernatant is removed and transferred into a conical bottom glass test tube. Then, the adsorbed analyte onto the precipitated proteins is eluted with acetonitrile and after centrifugation, the eluant is mixed with the supernatant obtained from the previous step. A few microlitres of toluene (as an extraction solvent) is added into the solution and the mixture is sucked into a glass syringe and pushed out in the tube for four times. The obtained cloudy solution is centrifuged to collect the extraction solvent. Then, the lower aqueous phase is withdrawn by a glass syringe to transfer the extraction solvent to the conical section of the tube. The method was validated and under optimal conditions, it was found that the method has low limits of detection (0.9 ng L−1) and quantification (3 ng L–1), good linearity (r2 = 0.9976), and satisfactory repeatability (relative standard deviation ≤9% for intra- (n = 8) and inter-day (n = 6) precisions). The extraction recovery and enrichment factor of AFM1 were 87% and 87, respectively. Finally, the proposed method was applied on different milk samples and concentration of aflatoxin M1 was determined in the studied samples. [ABSTRACT FROM AUTHOR]

The aim was to evaluate the changes in aflatoxin M1 (AFM1) and ochratoxin A (OTA) levels in human breast milk (HBM) during the first five postpartum months according to the sampling season in a cohort study from Şanlıurfa. From 78 healthy lactating mothers, HBM was taken at the 5–14 days postpartum (D5-14) and the 6th and 18th weeks postpartum (W6 and W18). Mycotoxin levels were analyzed with competitive ELISA. Generalized Estimating Equations with repeated measures (three-correlation matrix dimension) revealed a significantly higher mean AFM1 level at W6 than that on D5-14. AFM1 and OTA levels in winter and spring were considerably higher than that in summer and autumn. Maternal smoke exposure, body mass index, history of moldy food exposure, birth order, and breastfeeding type did not influence the results. Whilst season had a marked effect on the milk levels of both analytes, lactation stage affected AFM1 more notable than OTA. [ABSTRACT FROM AUTHOR]

The aim was to evaluate the levels of aflatoxin M1 (AFM1), ochratoxin A (OTA), zearalenone (ZEN), deoxynivalenol (DON) in human milk, and to investigate the relation between selected mycotoxin levels in breast milk and infantile growth in exclusively-breastfed infants under four months. Mycotoxin analysis was performed with commercial ELISA kits. Infants were weighed, and z scores of weight-for-age (WAZ) were calculated with WHO standards. The first quartile of the mycotoxin levels was classified in subgroups as low-level, the last quartile as high-level, and between them as middle-level. The subgroups of AFM1, OTA, and DON had similar infants' WAZ. When cases without maternal smoke exposure were selected and WAZ at birth, infant age, and gender were adjusted, higher infant WAZ on admission was detected in high-ZEN subgroup (p = 0.033). Further cohort studies in exclusively-breastfed infants and absence of maternal smoke exposure could clarify the effect of ZEN on infant growth. [ABSTRACT FROM AUTHOR]

The incidence of aflatoxin M1 (AFM1) contamination in raw milk and its association with herd types was investigated in the ten provinces of Southern China in 2018. A total of 797 raw milk samples were collected from Zhejiang, Jiangxi, Jiangsu, Hunan, Hubei, Hainan, Guangxi, Guangdong, Fujian, and Anhui provinces. The herd types were classified according to their characteristics. Among the 797 samples, 401 were owned by large-scale farms (herd size >500 cows, for dairy cow farming), 303 were owned by milk processing plants (herd size >500 cows, for dairy cow farming + milk processing), and 93 were owned by small farm cooperatives (herd size ≤500 cows, for dairy cow farming). The results revealed the presence of AFM1 in 94 of the 797 samples (11.80%). None of them was above 500 ng/L (Chinese and US limit standard), whereas 0.88% were above 50 ng/L (EU limit standard). The AFM1 concentrations in samples non-compliant with the EU standard were 52, 61, 88, 89.5, 164, 240, and 486 ng/L, respectively. It is important to note that samples exceeding the EU limit were mainly found in the area of Jiangsu and Guangxi provinces, and the herd type of milk processing plants. Hence, it is necessary to monitor and enforce the regulatory compliance of AFM1 levels in the raw milk from these specific areas and herd type. A total of 797 raw milk samples from three herd types, were collected from ten provinces of Southern China in 2018. Ninety-four of the 797 raw milk samples (11.80%) were positive for AFM1, and none of them was above the Chinese and US legal limit, only 0.88% of samples were above the EU limit. All of the exceed samples defined by EU limit were found in the area of Jiangsu and Guangxi provinces and belonged to milk processing plants. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) is a 4-hydroxylated metabolite of aflatoxin B1 (AFB1). It induces various toxicological effects including immunotoxicity. In the present study, we investigated the effects of AFM1 on immune system and its modulation by MicroRNA (miR)-155. AFM1 was administered intraperitoneally at doses of 25 and 50 µg/kg for 28 days to Balb/c mice and different immune system parameters were analyzed. The levels of miR-155 and targeted proteins were evaluated in isolated T cells from spleens of mice. Spleen weight was reduced in mice exposed to AFM1 compared to negative control. Proliferation of splenocytes in response to phytohemagglutinin-A was reduced in mice exposed to AFM1. IFN-γ was decreased in mice exposed to AFM1, whereas IL-10 was increased. Concentration of IL-4 did not change different in mice exposed to AFM1 compared to negative control. Exposure to AFM1 reduced the expression of miR-155. Significant upregulation of phosphatidylinositol-3, 4, 5-trisphosphate 5-phosphatase 1 (Ship1) and suppressor of cytokine signaling 1 (Socs1) was observed in isolated T cells from spleens of mice treated with AFM1, but the transcription factor Maf (c-MAF) was not affected. These results suggest that miR-155 and targeted proteins might be involved in the immunotoxicity observed in mice exposed to AFM1. The Immunotoxic effects of AFM1 on T cell functions. Exposure to AFM1 reduced the expression of miR-155. Significant upregulation of Ship1 and Socs1 was observed in isolated T cells from spleens of mice treated with AFM1, but the c-MAF was not affected. Since Ship1 is a functional target of miR-155 that modulates production of IFN-γ, miR-155 may play a role in AFM1-induced Th1 response suppression (DTH) through targeting of this protein (↑ increase; ↓ decrease). AFM1 inhibited cell-mediated immunity. Exposure of mice to AFM1 resulted in a significant decrease in expression of miR-155. Exposure of mice to AFM1 resulted in up-regulation of Ship1 and Socs1. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) is a 4-hydroxylated metabolite of aflatoxin B1 (AFB1). It induces various toxicological effects including immunotoxicity. In the present study, we investigated the effects of AFM1 on immune system and its modulation by MicroRNA (miR)-155. AFM1 was administered intraperitoneally at doses of 25 and 50 µg/kg for 28 days to Balb/c mice and different immune system parameters were analyzed. The levels of miR-155 and targeted proteins were evaluated in isolated T cells from spleens of mice. Spleen weight was reduced in mice exposed to AFM1 compared to negative control. Proliferation of splenocytes in response to phytohemagglutinin-A was reduced in mice exposed to AFM1. IFN-γ was decreased in mice exposed to AFM1, whereas IL-10 was increased. Concentration of IL-4 did not change different in mice exposed to AFM1 compared to negative control. Exposure to AFM1 reduced the expression of miR-155. Significant upregulation of phosphatidylinositol-3, 4, 5-trisphosphate 5-phosphatase 1 (Ship1) and suppressor of cytokine signaling 1 (Socs1) was observed in isolated T cells from spleens of mice treated with AFM1, but the transcription factor Maf (c-MAF) was not affected. These results suggest that miR-155 and targeted proteins might be involved in the immunotoxicity observed in mice exposed to AFM1. The Immunotoxic effects of AFM1 on T cell functions. Exposure to AFM1 reduced the expression of miR-155. Significant upregulation of Ship1 and Socs1 was observed in isolated T cells from spleens of mice treated with AFM1, but the c-MAF was not affected. Since Ship1 is a functional target of miR-155 that modulates production of IFN-γ, miR-155 may play a role in AFM1-induced Th1 response suppression (DTH) through targeting of this protein (↑ increase; ↓ decrease). AFM1 inhibited cell-mediated immunity. Exposure of mice to AFM1 resulted in a significant decrease in expression of miR-155. Exposure of mice to AFM1 resulted in up-regulation of Ship1 and Socs1. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) in milk is a problem of great concern. Current methods of detection require large instruments and need specific test sites. Therefore, it is necessary to establish a fast, convenient, and accurate detection method for AFM1. We established a system based on fluorescent microspheres containing a Eu3+ chelate named AFM1-POCT. These components comprised the AFM1-POCT kits. After refrigeration at 4°C for 12 months, the intra and inter assay coefficients of variability (CVs) for the kits were 4% and 5%, respectively. AFM1-POCT compared well with ultra-high-performance liquid chromatography (UHPLC) determination in the range 0.0121–2 μg/kg (paired samples test, P > 0.05). Aflatoxin B1 and G1 do not react with aflatoxin M1. By using the AFM1-POCT method, the detection time is shortened to 5 min, the accuracy is comparable to that of UHPLC, and convenience and range of application are improved. [ABSTRACT FROM AUTHOR]

Recently, higher contamination by aflatoxin M1 (AFM1) has been detected in many countries. Unfortunately, many tons of contaminated milk and milk byproducts are removed from the food chain to avoid human contamination; as a consequence of higher economic losses. Fewest number of studies are interested to AFM1 detoxification using lactic acid bacteria. In this study, AFM1-degradation using Lactobacillus paracasei BEJ01 (LPBEJ01) was tested in vitro. The preventive effect of LPBEJ01 against AFM1 immunobiological effects in mice are treated orally during 3 weeks with 100 µg AFM1, LPBEJ01 (2 × 109 CFU/ml∼2 mg/kg p.c.) and a mixture of AFM1 and LPBEJ01. In vitro LPBEJ01 was found able to absorb 98% of AFM1 (100 µg/ml) in liquid medium after 24 h and more than 95% of AFM1 could be eliminated after 24 h in a solid-state fermentation. Animals treated with AFM1 obtained lower body weight than the control ones. The mitogenic response of spleen mononuclear cells (SMCs) in vivo was higher in mice treated with AFM1. The SMC of mice treated with AFM1 produced lower levels of IL-2, higher levels IL-4 and no effect on IL-10 production. The peritoneal macrophages of mice that treated with AFM1 released less H2O2, while mice exposed orally with the mixture of AFM1 and LPBEJ01 produced higher levels. LPBEJ01 was safe and it did not have any sign of toxicity. It can be used as an additive for AFM1-detoxification contamination in the food chain in countries suffering from this problem. [ABSTRACT FROM AUTHOR]

The present study was carried out with the objectives to determine the occurrence of aflatoxin M1 (AFM1) in raw milk and identification of associated risk factors from three different types of animal farming systems. A total of 189 pooled raw milk samples were tested for AFM1 with enzyme linked immunosorbant assay (ELISA) as screening and high performance liquid chromatography with fluorescence detection (HPLC-FLD) as confirmatory techniques. AFM1 was found positive in 58% pooled milk samples with the mean level of 0.917 µg/L, while 50.8% and 36.5% samples were found above the legal limits set by European Commission (EC) and Food safety and standard authority of India (FSSAI), respectively for AFM1 in milk. Among all investigated risk factors, feeding of readymade concentrate feed and leftover household cereals, longer feed storage duration and feed storage quality were found significantly associated with presence of AFM1 in farm milk. High prevalence as well as levels of AFM1 in farm milk poses a health risk to the consumers especially children. Therefore, efforts are urgently required to create awareness among dairy farmers about aflatoxins contamination of feed and milk, to improve farm management practices and to control AFM1 level in milk below the legal limits. [ABSTRACT FROM AUTHOR]

Consumption of milks contaminated with aflatoxin M1 (AFM1) may result in serious health problems in humans. In the present study, English and Persian electronic databases were comprehensively searched for publications from 2005 to 2018. Results indicated that pooled prevalence of AFM1 contamination in milks of buffalo, cow, sheep, goat, and camel were 86, 86, 42, 34, and 30%, respectively. Furthermore, average concentration of AFM1 were 78.73, 40.86, 26.71, 24.30, and 20.63 ng/L for milks in the same order. Therefore, continued monitoring of AFM1 contamination in milks and dairy foodstuffs deserves a serious governmental consideration. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) contamination in 150 samples of milk, sold in market of Hisar city of Haryana, India, was investigated by using High Pressure Liquid Chromatography (HPLC). Out of these, 40 samples contained AFM1 at a concentration below the limit of detection (LOD) of 0.052 μg/kg. Among the AFM1 contaminated samples, 46 raw milk samples contained a concentration above the LOD but less than the limit of quantitation (LOQ), whereas 64 samples were above the LOQ. Of these samples, 31 exceeded the maximum limit of 0.5 μg/kg prescribed by FSSAI, India. Based on this study, the dietary intake of AFM1 for adults through consumption of milk was estimated. The results indicated that AFM1 contamination can be a food safety issue for raw and pasteurised milk consumed in India. Therefore, there is a need for a national monitoring programme to control the level of mycotoxins in milk. [ABSTRACT FROM AUTHOR]

Introduction: Milk consumption in Kenya supersedes other countries in East Africa. However, milk contamination with aflatoxin M1 (AFM1) is common, but the magnitude of this exposure and the health risks are poorly understood and need to be monitored routinely. This study aimed at assessing the awareness, knowledge and practices of urban and peri-urban farmers about aflatoxins and determining the levels of aflatoxin contamination in on-farm milk in a selected area within Nairobi County. Materials and methods: A cross-sectional study was undertaken to assess aflatoxin contamination levels of milk in Kasarani sub-county. A total of 84 milk samples were collected from small-holder dairy farms and analyzed for AFM1 using Enzyme-Linked Immunosorbent Assay (ELISA). Results and Discussion: Ninety nine percent of the samples (83/84) analysed were contaminated with AFM1. The mean aflatoxin level was 84 ng/kg with 64% of the samples exceeding the EU legal limit of 50 ng/kg. Whereas 80% of the farmers were aware of aflatoxin, there was no correlation between farmers' knowledge and gender with AFM1 prevalence. Conclusion: This study concludes that AFM1 is a frequent contaminant in milk and there is need to enhance farmers awareness on mitigation. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) is a 2B Group human carcinogens agent and introduces into the human diet by milk consumption. In the present study 257 raw, 143 pasteurized and 61 UHT milk samples were collected from markets in 117 cities throughout Iran, during winter 2017 and AFM1 contents were determined using a HPLC-FLD method after immunoaffinity clean-up. Mean recovery rates and relative standard deviations of the method were 90.6 ± 5.7%. AFM1 was detected in 252 of 461 (54.7%) samples (mean 31.3 ± 8.8 ng/L), ranging from <10 to 150 ng/L. Three samples (0.6%) exceeded the Iranian maximum limit of 100 ng/L. The mean AFM1 content was significantly higher in raw milk samples obtained from humid climate areas. The extrapolated concentration of AFB1 in dairy cattle feed based on the AFM1 value of milk was 1.96 µg/kg. The AFM1 contamination of milk seems not to be a serious public health concern in Iran. [ABSTRACT FROM AUTHOR]

The toxicity of aflatoxins results in cancer and liver disease. Several natural substances such as plants exhibited their ability to inhibit the initiation of aflatoxin carcinogenesis. The aim of this study was to evaluate the effect of Alchornea cordifolia on biomarkers in an aflatoxin B1 (AFB1) exposed rats. The contents of polyphenols, flavonoids and the antioxidant activity of A. cordifolia ethanolic leaf extract (EELac) were assessed. Groups of rats were treated orally with a daily dose of a mixture of AFB1 at a dose of 150 μg/kg body weight and EELac (50, 100 and 300 mg/kg body weight) for 21 days. Biomarkers of AFB1, such as the AFB1-lysine adduct and aflatoxin M1 were assayed in blood and urine, respectively, using an HPLC system with a fluorescence detector. The contents of polyphenols and flavonoids were 6783.23 ± 272.76 μg EAG/g and 10.54 ± 3.15% of dry matter, respectively. EELac showed a good antioxidant activity (IC50 = 12.65 ± 0.13 μg/mL). The administration of the mixture (AFB1 + EELac) at different doses significantly reduced the level of AFB1-lysine adduct from 14.04 ± 2.1 to 4.13 ± 0.9 ng/mg albumin and that of Aflatoxin M1 (AFM1) from 456 ± 16 to 220 ± 24 ng/mL (p <0.05). The rate of reduction was 70.58% for AFB1-lysine adduct and 51.75% for AFM1. A. cordifolia could be used in the prevention of toxicity induced by AFB1 on account of its high content in phenolic compounds. [ABSTRACT FROM AUTHOR]

In this survey aflatoxin, M1 was quantified in raw and processed milk from various areas of two big cities of Punjab province, i.e. Lahore and Multan. The results indicated that approximately 90% of the raw milk samples collected from Lahore city was contaminated with aflatoxin M1. Similarly, around 92% of the raw milk samples collected from Multan city was contaminated with aflatoxin M1. All samples of processed milk and tea whiteners were contaminated and 56% of the contaminated processed milk samples and 66% of the contaminated tea whitener samples were violating the maximum limits. The dietary exposure data of AFM1 among six different groups was calculated, which indicated that the male children population was the most vulnerable group to AFM1, up to 6.68 ng L−1 per day and the least affected one was the female group above 20 years of age with 1.13 ng L−1 per day. [ABSTRACT FROM AUTHOR]

An analytical method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) was validated and applied for the analysis of aflatoxin M1 (AFM1), ochratoxin A (OTA) and deoxynivalenol (DON) in infant formula and milk-based products for young children commercialized in Brazil. A total of 38 samples were evaluated, including 12 infant formula, 14 follow-on formula and 12 samples of milk-based products. AFM1 was detected in 12 (32%) samples, and seven (18%) samples contained AFM1 levels above the method limit of quantification in a concentration range between 0.013 and 0.067 ng mL−1 (0.026 ± 0.019). Two samples of milk-based products exceeded the maximum level (ML) fixed by the European Union for AFM1 in baby foods, however, all samples were in agreement with the levels established by the Brazilian regulation. OTA and DON were not detected in any of the analyzed samples. [ABSTRACT FROM AUTHOR]

During 2016-2017, 156 samples of fresh milk samples were collected from local markets of Karachi, Pakistan and analysed for aflatoxin M1 (AFM1) contamination using ELISA technique. AFM1 was detected in 143 (91.7%) samples, ranged from 20 to 3090 ng L−1 with a mean level of 346.2 ng L−1. In 125 (80.1%) samples, the AFM1 contamination was greater than the maximum limit (ML = 50 ng L−1) set by EU. However, in 51 (32.7%) samples, the AFM1 level was higher than the ML of 500 ng L−1 as assigned by the USA. Statistical analysis showed that the AFM1 level in milk samples from summer was significantly (p < 0.05) higher than that obtained in winter. It was concluded that the AFM1 levels in the tested samples appear to be a serious public health problem. Therefore, immediate measures should be taken and re-evaluation done for the procedures for farming, transportation, refrigeration, and storage for the control of AFM1 level in milk samples. [ABSTRACT FROM AUTHOR]

Aflatoxins are a major class of fungal toxins that have food safety importance due to their economic and health impacts. This pilot aflatoxin exposure biomonitoring study on 84 individuals was conducted in a rural (Ilumafon) and a semi-urban community (Ilishan Remo) of Ogun state, Nigeria, to compare aflatoxin exposures among the two population cohorts. First morning urine samples were obtained from the participants, and the urinary aflatoxin M1 (AFM1) levels were measured by a quantitative Helica Biosystems Inc. ELISA kit assay. About 99% (83 out of 84) of the urine samples had detectable AFM1 levels in the range of 0.06 to 0.51 ng mL−1 (median: 0.27 ng mL−1). The mean urinary AFM1 levels were significantly (p = 0.001) higher in the semi-urban population (0.31 ± 0.09 ng mL−1) compared to the rural population (0.24 ± 0.07 ng mL−1). There were, however, no significant differences in mean urinary AFM1 levels of males and females, and among children, adolescents and adults. This study indicates high aflatoxin exposure to the extent of public health concerns in the studied populations. Thus, more efforts are required for aflatoxin exposure monitoring and control in high-risk regions. [ABSTRACT FROM AUTHOR]

The occurrence of aflatoxin M1 in 69 milk samples collected in a south region of Italy in 2016 was evaluated. The samples were analysed using an automated method based on online SPE coupled with UHPLC tandem mass spectrometry. After a salt induced liquid' liquid extraction with acetonitrile to remove protein from milk, the extract was diluted with water and analysed using an automated online SPE MS/MS method. Among the analysed samples no one had AFM1 higher than the legally allowable limits whereas 71.4% of the other analysed samples were above the LOD of the method. The highest contamination level of AFM1 was found in pasteurised milk (44.39 ng kg-1). The results show the worrying and widespread of AFM1 contamination, highlighting the necessity of monitoring studies in order to evaluate the reduction of the maximum legal limit. [ABSTRACT FROM AUTHOR]

The present study evaluated the exposure of Southeast Mexican population to Aflatoxin M1 (AFM1) and M2 (AFM2) through the consumption of Oaxaca cheese. The intake of Oaxaca cheese was assessed via a food 7-day dairy questionnaire (N = 1100, 2014 and 2015). Thirty Oaxaca cheeses were randomly sampled, and the origin of the samples was also investigated. AFM1 and AFM2 were quantified by HPLC-FD. The exposure was assessed through the combination of the Probabilistic Density Functions (probabilistic approach). The percentage of the population at risk was calculated through the population exceeding the toxicological reference values (TDI). The risk assessment revealed that the population at higher risk to AFM1 and AFM2 was the children, followed by the adolescents and adult women. To our knowledge, the present study is the first to assess the exposure risk of different age groups of a population to AFM1 and AFM2 through the consumption of cheese. [ABSTRACT FROM AUTHOR]

Although the mycological content of white cheese has been extensively studied, little data is available concerning the existence of aflatoxin M1 (AFM1) in Egyptian white cheese. Egyptian legislation does not allow for AFM1 in milk or milk products. In this study, trace amounts of AFM1 contamination were detected in laboratory manufactured Egyptian white cheese using either single or triple quadrupole techniques after artificial exposure of AFM1 to raw milk used for the cheese making. Validation data proved that the triple quadrupole method was more sensitive and selective than the single quadrupole method for AFM1 analysis. The limit of detection (LOD) and the limit of quantification (LOQ) were 0.0625 ppb and 0.125 ppb for the triple quadrupole method and 0.125 ppb and 0.250 ppb for the single quadrupole method. Recovery of AFM1 ranged from 87%to 92%for single quadrupole and 89% to 99% for triple quadrupole using mass spectrometer techniques. Linear regression produced linear standard curves with coefficients of determination of regression of 0.9981 and 1.000 for the single and triple quadruples, respectively. Although both methods were able to measure AFM1, the tandem mass spectrometer produced results that were more reliable. [ABSTRACT FROM AUTHOR]

Raw cow, goat and sheep milk samples were collected in different regions of Croatia during spring and autumn 2016. Aflatoxin M1 (AFM1) concentrations were measured in the following ranges (ng/kg): cow milk 0.93–85.4; goat milk 2.0–18.6; sheep milk 2.27–11.2. AFM1 levels exceeding the European Union maximum residue levels of 50 ng/kg were found in two cow milk samples in spring and 10 cow milk samples in autumn. The probable daily intakes (PDIs) for all three dairy species were from 0.0108 to 0.0165 ng/kg b.w./day and contributing 1.08–1.65% to the proposed provisional maximum tolerable daily intake (PMTDI; 1 ng/kg b.w./day), indicating low risk exposure for consumers. The mean positive cow milk PDI was 0.15 ng/kg b.w./day, contributing 15.2% to the PMTDI. [ABSTRACT FROM AUTHOR]

In the current investigation, attempts were made to determine if ozone treatment can affect the aflatoxin M1 (AFM1) content of milk. Aflatoxin M1 by a pre-determined concentration of 0.56 µg/ Kg was added to milk. Milk samples, were then exposed to gaseous ozone (80 mg/min) in containers for durations of 0, 0.5, 1, 2, 5 and 10 min. The longer exposure time to ozone was more efficient in breaking down the AFM1 in milk. Results indicated that AFM1 was reduced by 50%, when milk was ozonated at for 5 min. The pH and oxidation value of milk did not change significanty as a result of the treatments. The β-carotene content was significantly reduced and the total microbial count in milk decreased parallel to the longer exposure time. Also, it was through this longer exposure time by ozone that the L* values of milk increased significantly (p < 0.05), while the b* values significantly decreased. To the best of our knowledge, this is the first study that uses ozone to degrade AFM1 in milk. [ABSTRACT FROM AUTHOR]

The aim of this systematic review is to provide information regarding the incidence and levels of aflatoxin M1 (AFM1) in raw and heat processed cow's milk in Serbia during 2015–16 and to compare these with collected data on the occurrence of AFM1 in raw milk and dairy products during the last decade in our region. Estimation of dietary exposure (EDI) and hazard index (HI) calculations for different age groups of the population were also carried out, based on the AFM1 content of milk samples and on available food consumption data in Serbia. AFM1 was detected in 69.9% (984/1408) of raw milk samples in 2015 versus 84.9% (3094/3646) in 2016, while in heat-processed milk, AFM1 was detected in 77.8% (364/468) in 2015 versus 98.5% (753/765) in 2016. On the basis of the obtained results, 450 (9%) of raw and 14 (1.1%) of heat-processed milk samples were contaminated with AFM1 levels above the maximum permitted level in Serbia (0.25 μg kg−1). However, a large percentage of raw and heat processed milk in Serbia (30.1% and 17.3%, respectively) was contaminated with AFM1 levels above the maximum permitted level regulated in the European Union (0.05 μg kg−1). Therefore, in order to protect consumer health, it is extremely important to further control the level of aflatoxins in milk, and this should be considered as a high priority for risk management actions. [ABSTRACT FROM AUTHOR]

This survey was conducted to determine the occurrence and levels of aflatoxin M1(AFM1) in 250 breast milk samples of lactating mothers, obtained from urban and rural regions of Shahrekord, Iran. Moreover, the association between AFM1occurrence levels and dietary factors was assessed. AFM1analysis was carried out using the competitive enzyme-linked immunosorbent assay technique for screening and high-performance liquid chromatography with fluorescence detection (HPLC–FLD) for confirmatory purposes. The toxin was detected in 39 samples (15.6%), ranging from 11.1 to 39.3 ng/l, of which 8 samples (3.2%) had levels above the Iranian national standard limit (25 ng/l). AFM1occurrence and levels in breast milk samples obtained from rural regions were significantly higher (P ≤ 0.05) than those obtained from urban ones. It might be due to the different dietary patterns in these regions. It was found that dietary habits with more tendencies to consume bread, rice and non-alcoholic beer beverage significantly increased (P ≤ 0.05) the risk of AFM1occurrence in breast milk. In addition, higher consumption of bread, olive and traditional cream significantly increased (P ≤ 0.05) the levels of AFM1in breast milk samples. Further investigations should be performed to determine more precisely the association between AFM1occurrence and dietary factors and also the risk of infant exposure to this mycotoxin. [ABSTRACT FROM PUBLISHER]

During the last 3 years, high aflatoxin M1 (AFM1) concentrations in milk and dairy products occurred in Serbia. It resulted in periodical change of the official regulations regarding maximum levels (MLs) of AFM1 as set by the Serbian Government. The aim of this study was to compare the occurrence of AFM1 in raw milk and dairy products during 2015 and also to determine whether there were some differences in AFM1 level among seasons. The AFM1 level exceeded the European Union ML in 29.3% of raw milk and 4.2% of milk product samples. The highest level of AFM1 in raw milk was found during the autumn season, while during the rest of the 2015, it was significantly lower. Although the improvement of dairy products safety was evident in 2015 when compared to 2013 and 2014, the cause of high concentrations in raw milk remained unresolved yet. This study indicates that dairy plants introduced control measures and refused reception of too high contaminated raw milk. [ABSTRACT FROM PUBLISHER]

Although the mycological content of white cheese has been extensively studied, little data is available concerning the existence of aflatoxin M1 (AFM1) in Egyptian white cheese. Egyptian legislation does not allow for AFM1in milk or milk products. In this study, trace amounts of AFM1contamination were detected in laboratory manufactured Egyptian white cheese using either single or triple quadrupole techniques after artificial exposure of AFM1to raw milk used for the cheese making. Validation data proved that the triple quadrupole method was more sensitive and selective than the single quadrupole method for AFM1analysis. The limit of detection (LOD) and the limit of quantification (LOQ) were 0.0625 ppb and 0.125 ppb for the triple quadrupole method and 0.125 ppb and 0.250 ppb for the single quadrupole method. Recovery of AFM1ranged from 87% to 92% for single quadrupole and 89% to 99% for triple quadrupole using mass spectrometer techniques. Linear regression produced linear standard curves with coefficients of determination of regression of 0.9981 and 1.000 for the single and triple quadruples, respectively. Although both methods were able to measure AFM1, the tandem mass spectrometer produced results that were more reliable. [ABSTRACT FROM AUTHOR]

A sensitive and rapid magnetic nanoparticle-based fluorescent immunoassay for the determination of aflatoxin M1 in raw milk was developed. Aflatoxin M1 was converted to aflatoxin M1-o-carboxymethyl oxime. The aflatoxin M1-oxime was used for the preparation of aflatoxin M1-oxime-fluoresceinamine conjugate through the carbodiimide reaction. The aflatoxin M1-oxime-fluoresceinamine conjugate was characterized by ultraviolet–visible and infrared spectroscopy. Magnetic nanoparticles (Fe3O4) were synthesized and modified by 3-(aminopropyl)triethoxysilane. The size of initial (139 nm) and functionalized magnetic nanoparticles (147 nm) was determined by particle analysis. The optimal mass of immobilized antibody (25 µg) and optimal concentration of aflatoxin M1-oxime-fluoresceinamine conjugate (15 µg mL−1) for magnetic nanoparticle-based fluorescent immunoassay were determined. The developed immunoassay provided a linear aflatoxin M1 concentration range from 3.0 to 100 pg mL−1in bovine milk. The detection limit was 2.9 pg mL−1. The results of aflatoxin M1 magnetic nanoparticle-based fluorescent immunoassay in heat-treated milk and phosphate-buffered saline at pH 6.6 were compared. The influence of the somatic cell count, pH, and fat concentration in bovine milk on the aflatoxin M1 immunoassay was investigated. The influence of the milk species on the immunoassay was also characterized. The high fat concentration ovine milk depressed the sensitivity of the aflatoxin M1 immunoassay. [ABSTRACT FROM PUBLISHER]

The objectives of the study were to determine the aflatoxin M1 content in human milk samples in Vojvodina, Serbia, and to assess the risk of infants' exposure to aflatoxins food contamination. The growth ofAspergillus flavusand production of aflatoxin B1 in corn samples resulted in higher concentrations of AFM1 in milk and dairy products in 2013, indicating higher concentrations of AFM1 in human milk samples in 2013 and 2014 in Serbia. A total number of 60 samples of human milk (colostrum and breast milk collected 4–8 months after delivery) were analyzed for the presence of AFM1 using the Enzyme Linked Immunosorbent Assay method. The estimated daily intake of AFM1 through breastfeeding was calculated for the colostrum samples using an average intake of 60 mL/kg body weight (b.w.)/day on the third day of lactation. All breast milk collected 4–8 months after delivery and 36.4% of colostrum samples were contaminated with AFM1. The greatest percentage of contaminated colostrum (85%) and all samples of breast milk collected 4–8 months after delivery had AFM1 concentration above maximum allowable concentration according to the Regulation on health safety of dietetic products. The mean daily intake of AFM1 in colostrum was 2.65 ng/kg bw/day. Results of our study indicate the high risk of infants' exposure, who are at the early stage of development and vulnerable to toxic contaminants. [ABSTRACT FROM AUTHOR]

The study reports the results of testing the sensitivity of an early warning sampling plan for detecting milk batches with high aflatoxin AFM1concentration. The effectiveness of the method was investigated by the analysis of 9017 milk samples collected in Italian milk processing plants that applied control plans with different action limits (AL). For those milk processing plants where 30 ng kg−1AL has been applied, the AFM1contamination was significantly lower at or above the 95th percentile of the milk samples when compared with plants that used 40 ng kg−1AL. The results show that the control plan can be used effectively for early warning of occurrence of high AFM1contamination of milk and to carry out pro-active measures to limit the level of contamination. Estimation of dietary exposure was also carried out, based on the aflatoxin M1content of the milk samples and on Italian food consumption data. Estimated Daily Intakes (EDI) and Hazard Indices (HI) were calculated for different age groups of the population. HIs show that no adverse effects are expected for the adult population, but in the case of children under age three, the approximate HI values were considerably higher. This underlines the importance of the careful monitoring and control of aflatoxin M1in milk and dairy products. [ABSTRACT FROM PUBLISHER]

A method developed for the simultaneous analysis of aflatoxin M1, abamectin, doramectin, eprinomectin, ivermectin, moxidectin, acephate, azinphos-ethyl, azinphos-methyl, diazinon, methamidophos, methidathion, mevinphos, pirimiphos-ethyl and pirimiphos-methyl in whole raw milk, based on the QuEChERS method for extraction and clean-up, with detection and quantification by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) is described. The method was validated according to parameters of the Analytical Quality Assurance Manual from the Brazilian Ministry of Agriculture and Commission Decision 2002/657/EC, and proved suitable for analysis of these analytes within the proposed working range, with recovery values between 77% and 110%, a standard deviation lower than 20%, limits of detection between 0.05 and 0.99 µg l−1, and limits of quantification between 0.15 and 1.98 µg l−1. Samples from animals treated with abamectin, doramectin, ivermectin and diazinon were analysed by the validated method. Residues of aflatoxin M1were also found in field samples at levels below the established maximum residue limit. [ABSTRACT FROM AUTHOR]

This study aims to detect aflatoxins (AFs) in dairy cow feed, milk and milk products using a high-performance liquid chromatography coupled with fluorescence detection (HPLC-FLD) method. All the validation parameters met the method performance criteria of the European Union. The samples comprised 76 dairy cow feeds and 205 milk and milk products (including yoghurt and yoghurt-based beverage,ayran). AFs were present in 26.3% of the feed samples. Two feed samples exceeded the maximum limit (ML) of 5 µg kg−1for AFB1as established by the EU. Nineteen milk samples (21.1%) contained aflatoxin M1(AFM1) of which three exceeded the EU ML of 0.05 µg l−1. In addition, only two yoghurt samples and oneayransample contained AFM1, but the levels were lower than the EU ML. [ABSTRACT FROM PUBLISHER]

Aflatoxin M1(AFM1) contamination in raw milk from household cows fed with sunflower seedcakes or sunflower-based seedcake feeds was determined in 37 milk samples collected randomly from different locations in Singida region, Tanzania. Aflatoxin B1(AFB1) contamination in sunflower-based seedcake feed was determined in 20 feed samples collected from the same household dairy farmers. The samples were analysed by RP-HPLC using fluorescent detection after immunoaffinity column clean-up. Recoveries were 88.0% and 94.5%, while the limits of detection (LOD) were 0.026 ng mL−1and 0.364 ng g−1for AFM1and AFB1, respectively. Of the analysed cow’s milk samples, 83.8% (31/37) contained AFM1, with levels ranging from LOD to 2.007 ng mL−1, exceeding both the European Commission (EC) and Tanzania Food and Drug Authority (TFDA) limit of 0.05 ng mL−1. Of the contaminated samples, 16.1% exceeded the Codex Alimentarius limit of 0.5 ng mL−1. AFB1was present in 65% (13/20) of the feed samples with levels ranging from LOD to 20.47 ng g−1, 61.53% exceeding the TFDA and EC maximum limits of 5 ng g−1for complete dairy animal feed. The observed AFM1and AFB1contamination necessitates the need to raise awareness to dairy farmers in Tanzania to safeguard the health of the end-users. [ABSTRACT FROM PUBLISHER]

A total of 600 samples of milk from different species [buffalo (150), cow (150), goat (150), and sheep (150)] were analyzed for aflatoxin M1 (AFM1) contamination using high-performance liquid chromatography and enzyme-linked immunosorbent assay (ELISA) methods. AFM1contamination was found in buffalo (38.6%), cow (45.3%), goat (33.3%), and sheep (36.6%) milk. The mean value of AFM1was 0.026 µg L−1in buffalo, 0.018 µg L−1in cow, 0.014 µg L−1in goat, and 0.017 µg L−1in sheep milk. In all types of milks, the level of AFM1concentration was higher in milk obtained from urban and semi-urban areas, whereas it was found minimal in milk from rural areas. The results of the analysis of AFM1level by the ELISA analysis (ng L−1) was observed in 46.5% of all samples. The amount of AFM1in 16% buffalo, 44% cow, 10% goat, and 12% sheep milk samples was above the maximum tolerance limit accepted by the European Union. [ABSTRACT FROM PUBLISHER]

Aflatoxin M1(AFM1) occurrence was analysed in 80 samples of milk and 21 samples of infant formulae on the Serbian market, using high-performance liquid chromatography with fluorescence detection. All milk samples collected in 2013 showed AFM1 contamination in the range 0.02–0.32 μg kg−1, with a mean level of 0.13 μg kg−1. The EU maximum level for AFM1 in milk (0.05 μg kg−1) was exceeded in 75% of the samples. In 2014, AFM1 was found in 83%, 70%, 80% and 58% of the samples collected in April, July, September and December, respectively, exceeding the limit in 5% of the samples taken in July. The additional number of liver cancer cases per year associated with exposure to AFM1 was estimated to be 0.004 in the adult population. Regarding infant formulae, AFM1 was found in only one sample. [ABSTRACT FROM PUBLISHER]

A total of 635 raw milk samples from 45 dairy farms, from three regions of São Paulo state – Brazil, were evaluated during 15 months for aflatoxin M1(AFM1). AFM1was determined by high performance liquid chromatograph with fluorescence detection. AFM1was detected (>0.003 µg kg−1) in 72.9%, 56.3% and 27.5% of the samples from Bauru, Araçatuba and Vale do Paraíba regions, respectively. The mean AFM1contamination considering all the samples was 0.021 µg kg−1. Furthermore, the concentration of AFM1was quite different among Bauru (0.038 µg kg−1), Araçatuba (0.017 µg kg−1) and Vale do Paraíba (<0.01 µg kg−1) regions. Only three samples (0.5%) had higher contamination than the tolerated limit in Brazil (0.50 µg kg−1) and 64 samples (10.1%) had a higher contamination than the maximum limit as set by the European Union (0.050 µg kg−1). The estimated AFM1daily intake was 0.358 and 0.120 ng kg−1body weight per day for children and adults, respectively. [ABSTRACT FROM AUTHOR]

Occurrence of aflatoxin M1 (AFM1) was determined in 254 samples of raw milk obtained from dairy cow farms of Qazvin Province, Iran. Aflatoxin M1 analysis was carried out by using the competitive enzyme-linked immunosorbent assay technique for screening and high-performance liquid chromatography with fluorescence detection for confirmatory purposes. The limit of detection and quantification of the confirmatory method were 0.003 and 0.01 µg/l, respectively. Aflatoxin M1 was detected in 204 analysed samples (80.3%), ranging from 0.011 to 0.321 μg/l, and 144 samples (56.7%) had levels above the Iranian national standard limit of 0.050 μg/l. Considering the seasonal variability, the occurrence and levels of AFM1 in samples obtained in winter were significantly higher (P < 0.05) than those obtained in summer. The results of this survey indicate the usefulness of a monitoring programme to supervise food safety for consumers. [ABSTRACT FROM AUTHOR]

Chronic exposure to aflatoxins, and especially to aflatoxin B1(AFB1), causes hepatocellular carcinoma with prevalence 16–32 times higher in developing compared with developed countries. Aflatoxin M1(AFM1) is a monohydroxylated metabolite from AFB1 that is secreted in milk and which can be used as a biomarker of AFB1 exposure. This study aimed to determine AFM1 levels in human breast milk using immunoaffinity column clean-up with HPLC and fluorescence detection. Breast milk samples were obtained from 50 nursing mothers. Volunteers filled in a questionnaire giving their consent to analyse their samples as well as details of their socioeconomic, demographic and clinical data. The possible dietary sources of aflatoxins were assessed using a food frequency questionnaire. A total of 90% of the samples tested positive for AFM1, with a mean of 5.2 ng l−1and a range of 0.9–18.5 ng l−1. The study demonstrated a high frequency of exposure of mothers and neonates to AFB1 and AFM1 in Colombia, and it points out the need to regulate and monitor continuously the presence of aflatoxins in human foods. Further research is needed in order to determine the presence of other mycotoxins in foods and in human samples as well as to devise protection strategies in a country where mycotoxins in human foods are commonly found. [ABSTRACT FROM PUBLISHER]

Aflatoxin B1 (AFB1) and M1 (AFM1) are mycotoxins produced by numerous Aspergillus species in pre- or post-harvest cereals and milk. AFB1 and AFM1 display a potent economic loss in livestock and also cause severe immunological problems. The aims of this study were to: evaluate a new AFB1 and AFM1-binding/degrading micro-organism for biological detoxification; examine its ability to degrade AFB1 and AFM1 in liquid medium; and evaluate its potential for in vivo preventative effects against AFB1- and AFM1-induced immunomodulation in mice. Lactobacillus plantarum MON03 (LP) isolated from Tunisian artisanal butter was found to display significant binding ability to AFB1 and AFM1 in PBS (i.e. 82% and 89%, respectively) within 24 h of incubation and able to tolerate gastric acidity, have strongly hydrophilic cells surface properties, and adhere efficacy to Caco-3 cells in vitro. The in vivo study was conducted using Balb/c mice that received by oral gavage vehicle (control), LP only (2 × 109 CFU/L, ∼2 g/kg BW), AFB1 or AFM1 alone (0.25 and 0.27 mg/kg, respectively), or AFB1 + LP or AFM1 + LP daily for 15 days. Compared to in control mice, treatments with AFB1 and AFM1 led to significantly decreased body weight gains, histopathological changes, and decrements in all hematologic and immune parameters assessed. Co-treatment with LP strongly reduced the adverse effects of each mycotoxin. In fact, the mice receiving AFB1 + LP or AFM1 + LP co-treatment displayed no significant differences in the assayed parameters as compared to the control mice. By itself, the bacteria alone had no adverse effects in the mice. From these data, it is concluded that the tested bacteria could be beneficial in biotechnology detoxification of contaminated food and feed for humans and animals. [ABSTRACT FROM AUTHOR]

Aflatoxins are toxic fungal metabolites, which can be found in feed. Aflatoxin M1(AFM1) is excreted into milk when ruminants ingest aflatoxin B1contaminated feedstuffs. Due to its carcinogenic potential, contamination of milk and dairy products with AFM1may pose a risk for consumers. Hence, it is considered a public health concern. In this survey, the level of AFM1contamination of dairy products marketed in Costa Rica was determined by enzyme-assisted extraction, immunoaffinity clean-up and high-performance liquid chromatography coupled with a fluorescent detector (HPLC-FLD) in fluid milk (n = 70), fresh cheese (n = 70) and sour cream (n = 70) collected at local convenience stores and supermarkets. AFM1concentrations in milk and fresh cheese ranged from 19 to 629 ng/L and from 31 to 276 ng/L, with mean values of 136 ng/L and 74 ng/L, respectively, whereas none of the sour cream samples analysed tested positive for this aflatoxin. In 30 milk samples, and 10 cheese samples, AFM1concentrations surpassed threshold concentrations as established by the European Commission. Thus, sour cream and – to a lesser extent – cheese manufacturing seems to reduce the amount of AFM1present in milk, possibly due to fraction redistribution or microbiological degradation. The survey results reveal improper quality control procedures in the Costa Rican dairy industry. Therefore, a surveillance programme for dairy products in our country is recommended. [ABSTRACT FROM AUTHOR]

Aflatoxins are fungal toxins, which may be found in food and due to negative health effects, they are of major concerns for human health and food industries. Aflatoxin M1 contamination in dairy products in Arak, Iran, 2013 was evaluated using ELISA method. Sample groups were comprised of 111 samples, including pasteurized milk ( n = 56), raw milk ( n = 16) and cheese ( n = 39), and were analyzed for AfM1 content. The results showed that 93.7% of the samples were positive with the total average concentration of 85.8 µg/L in milk and 30.39 µg/kg in cheese. Moreover, AfM1 of 94.4% of milk samples and 92.3% of cheese samples was above the standards of Iran and EU. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 (AFM1) is a mycotoxin produced by numerous Aspergillus species in pre- or post-harvest cereals and milk. Exposure to AFM1 imparts potent economic losses in the livestock industry. Toxicologically, it also causes severe immune system problems. The aims of this study were to evaluate a new AFM1-binding/degrading microorganism for biologic detoxification, to examine its ability to degrade AFM1 in liquid medium, and to evaluate its potential for in vivo preventative effects against AFM1-induced immunotoxicity and genotoxicity in mice. Lactobacillus plantarum MON03 (LP) isolated from Tunisian artisanal butter was found to display significant binding ability to AFM1 in PBS (93%) within 24 h of incubation. Further, the LP was able to tolerate gastric acidity, bile salts, and adhere efficiently to Caco-3 cells in vitro. The in vivo study used Balb/c mice that received either vehicle (control), LP only (at 1 × 109 CFU/L, ∼1 mg/kg bw), AFM1 (100 mg/kg bw), or AFM1 + LP daily for 15 days (by gavage); two other groups received a single dose of colchicine (4 mg/kg) or mitomycin C (1 mg/kg) as positive controls for induction of micronuclei and chromosomal aberrations, respectively. The results showed that, compared to in control mice, AFM1 treatment led to significantly decreased body weight gains, and caused cytotoxic/genotoxic effects as indicated by increases in frequencies of polychromatic erythrocytes, as well as those with micronucleation (PCEMN) and chromosomal aberrations, among bone marrow cells. The concurrent administration of LP with AFM1 strongly reduced the adverse effects of AFM1 on each parameter. Mice receiving AFM1 + LP co-treatment displayed no significant differences in the assayed parameters as compared to the control mice. By itself, the bacteria caused no adverse effects. Based on the data, it is concluded that the test bacteria could potentially be beneficial in the detoxification of AFM1-contaminated foods and feeds for humans and animals. [ABSTRACT FROM AUTHOR]

In this study, an indirect competitive chemiluminescent enzyme immunoassay (ic-CLEIA) for determining aflatoxin M1(AFM1) in milk products has been developed. A luminol–hydrogen peroxide chemiluminescence system catalysed by horseradish peroxidase (HRP) was used as the signal detecting system. The effects of several factors, including concentration and pH of phosphate buffer, dilution ratio of antibody and antigen and other relevant variables on the immunoassay, were studied and optimised by single-factor experiments. The developed method presented an IC50of 0.05 ng/mL, a detection limit of 0.01 ng/mL and a linear range from 0.018 to 0.13 ng/mL. This method has been successfully applied to the evaluation of AFM1in milk products, the recoveries ranging from 71.9% to 109.0%. A good correlation with the commercial available ELISA kit for AFM1(r= 0.9978) was obtained, indicating that the ic-CLEIA method developed can be used to determine AFM1in real samples. [ABSTRACT FROM PUBLISHER]

A survey of aflatoxin M1 (AFM1) contamination in packaged milk and infant formula milk samples in the Goan market, India, was conducted using high performance liquid chromatography, association of analytical communities approved commercial kit and a sensitive chemiluminescent sandwich enzyme-linked immunosorbent assay (ELISA). A total of 72 samples of infant formula milk food (18) and packaged milk samples (54) was analysed. One hundred per cent of the analysed samples exceeded the European Communities recommended limits (50 ng/L) and 75% of the samples exceeded Codex Alimentarius, Food Safety and Standards Authority of India (FSSAI) and US Food and Drug Administration recommended limits (500 ng/L). The range of contamination of AFM1 was found lower in infant milk formula (501–713 ng/L) than liquid milk (511–809 ng/L). The methods were also compared for their performance, and ELISA was found to be most suitable for analysis of low-level AFM1 contamination in milk. [ABSTRACT FROM AUTHOR]

Aflatoxin M1 contamination in dairy products is a risk when feedstuff contaminated with aflatoxin B1 produced by moulds is consumed by milk-producing animals. Milk can be screened for aflatoxin M1 at the European Union maximum limit of 50 ng l−1 by a lateral flow test, the MRLAFMQ (Aflatoxin M1) Test. The method takes 15 min with no milk dilution or a sample preparation step. The lateral flow assay was validated at the Technology and Food Science Unit of the Institute for Agricultural and Fisheries Research (ILVO-T&V) according to European Union guidelines using fortified raw milk samples. A detection capability of 50 ng l−1 was demonstrated with a false negative rate lower than 2% at 50 ng l−1 and a false positive rate of less than 0.3%. Quantitative readings had a mean bias of +2 to 6 ng l−1 at 50 ng l−1 with a standard deviation of 5–8 ng l−1. Based on the validation results, the test could be considered appropriate for milk screening prior to milk unload at dairies. [ABSTRACT FROM AUTHOR]

Due to their nutritional value, dairy products are popular in Iran. However, several reports have demonstrated that aflatoxin M1 (AFM1) contamination of milk and dairy products are challenging for human health, especially children. This manuscript is a review of some reports about the occurrence of AFM1 in Iranian dairy products published between 2005 and 2013. The studies analyzed a total of 11 107 dairy products samples composed of raw milk, UHT milk, pasteurized milk, traditional cheese, UF cheese, cream cheese, feta cheese, white cheese, butter, ice cream, infant milk products, Doogh and yoghurt. Current AFM1 analysis was conducted by various methods including thin layer chromatography, high-performance liquid chromatography and enzyme-linked immunoassays; but the ELISA method is mostly used in Iran because of its rapidity, simplicity and cheapness. The mean contamination level of AFM1 in autumn and winter samples was significantly higher than spring and summer. According to European Commission limit, i.e. 50 ng/kg, the reported range of contamination in analyzed dairy products exceeded the limit was in the range of 0-100%. [ABSTRACT FROM AUTHOR]